AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
39,950
-550 (-1.36%)
At close: Dec 9, 2025
159.42%
Market Cap946.90B
Revenue (ttm)8.97B
Net Income (ttm)-877.63M
Shares Out23.21M
EPS (ttm)-39.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume603,140
Average Volume1,418,330
Open41,000
Previous Close40,500
Day's Range39,850 - 41,500
52-Week Range11,980 - 46,950
Beta1.61
RSI55.67
Earnings Daten/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.